Evaluation of recurrent esophageal variceal rupture post-endoscopic band ligation: A case report
DOI: https://doi.org/10.33024/minh.v8i4.895
Endoscopic Band Ligation Esophageal Variceal Bleeding Liver Cirrhosis Portal Hypertension
Abstract
Background: One serious side effect of portal hypertension that is often seen in individuals with liver cirrhosis is esophageal varices. Even after Endoscopic Band Ligation (EBL), there is a significant chance that these varices may bleed again. Uncontrolled portal pressure, therapeutic noncompliance, and concomitant gastrointestinal disorders are often linked to rebleeding.
Purpose: To evaluate the risk factors influencing the success of Endoscopic Band Ligation (EBL) in preventing rebleeding in patients with a history of esophageal variceal rupture.
Method: Using a descriptive case study approach with an eye on one patient undergoing treatment at a hospital, this research medical records provided data, which were then descriptively examined to assess clinical factors, forms of treatment given, and patient condition over time.
Results: Results revealed that individuals with hepatic cirrhosis brought on by a hepatitis B infection are very likely to rebleed. Among the contributing causes were uncontrolled portal hypertension, congestive gastropathy, gastrointestinal bleeding-related chronic anemia, and inadequate therapeutic adherence. Furthermore important were eating behaviors that aggravate gastrointestinal problems.
Conclusion: Stopping rebleeding calls for a multidisciplinary strategy. Monitoring portal pressure, following beta-blocker and antiviral treatment, and teaching patients about long-term care are among these aspects. To confirm these results, further research using bigger sample sizes is required.
Downloads
References
Abdo, M., Moustafa, A., Mostafa, I., Abdelbary, M. S., Elatar, G., Rahim, A. A., & Abdelhalim, H. (2022). To coagulate, ligate, or both: a randomized study comparing the safety and efficacy of two endoscopic approaches for managing gastric antral vascular ectasia in cirrhotic patients. Egyptian Liver Journal, 12(1), 1–8.
An, S., Jang, E., & Lee, J. H. (2020). Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A Review. Evidence-Based Complementary and Alternative Medicine, 1(1), 1–11.
Baye, M. L., Abay, Z., Tesfaye, T., Ahmed, E., Arage, G., Zewude, E. A., & Anley, D. T. (2023). Gastroesophageal variceal hemorrhage in patients with chronic liver diseases attending university of Gondar Specialized comprehensive hospital in Ethiopia: Institutional based cross-sectional study. Heliyon, 9(4), 1–8.
Blasi, A., Machlab, S., Risco, R., Costa-Freixas, J. P., Hernández-Cely, G., Horta, D., & Cardenas, A. (2021). A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation. JHEP Reports, 3(6), 1–6.
Cetin, E. G., Demir, N., & Sen, I. (2020). The relationship between insulin resistance and liver damage in non-alcoholic fatty liver patients. The Medical Bulletin of Sisli Etfal Hospital, 54(4), 411.
Chi, X. T., Lian, T. T., & Zhuang, Z. H. (2024). Advances in the endoscopic management of gastric varices. Digestive Endoscopy, 36(8), 884–894.
de Franchis, R. (2020). Non-invasive (and minimally invasive) diagnosis of oesophageal varices. Journal of Hepatology, 49(4), 520–527.
Deng, Y., Jiang, T., Chen, L., Mou, H. J., Tuo, B. G., Shi, G. Q., & Jiang, Y. (2024). Evaluation of the efficacy and safety of endoscopic band ligation in the treatment of bleeding from mild to moderate gastric varices type 1. World Journal of Gastroenterology, 30(5), 440–449.
Diaz-Soto, M. P., & Garcia-Tsao, G. (2022). Management of varices and variceal hemorrhage in liver cirrhosis: a recent update. Therapeutic Advances in Gastroenterology, 15(1), 1–12.
Elbahr, O., Kamal, A., Alsebaey, A., Amin, M., Abbasy, M., Edris, A., & Gad-Allah, A. E. naser. (2021). Self-expandable metallic stents (SEMS) in esophageal varices post-band ulcer refractory bleeding: a retrospective study. Egyptian Liver Journal, 11(1), 1–7.
Ghany, M. G., Buti, M., Lampertico, P., & Lee, H. M. (2023). Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference. Journal of Hepatology, 79(5), 1254–1269.
Giri, S., Sundaram, S., Jearth, V., & Bhrugumalla, S. (2022). Predictors of early bleeding after endoscopic variceal ligation for esophageal varices: a systematic review and meta-analysis. Clinical and Experimental Hepatology, 8(4), 267–277.
Gralnek, I. M., Camus Duboc, M., Garcia-Pagan, J. C., Fuccio, L., Karstensen, J. G., Hucl, T., & Triantafyllou, K. (2022). Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 54(11), 1094–1120.
Hassan, F. E., Mahamed, Z. A., Abdelmalek, M. O., & Mostaf, N. M. (2023). Effect of Nursing Instructions on Esophageal Varices Recurrence After Endoscopic Band Ligation. Assiut Scientific Nursing Journal, 38(1), 59–68.
Helal, A., Vakharia, K., Brinjikji, W., Carlson, M. L., Driscoll, C. L. W., Van Gompel, J. J., & Cloft, H. (2022). Preoperative embolization of jugular paraganglioma tumors using particles is safe and effective. Interventional Neuroradiology, 28(2), 145–151.
Ibrahim, A., Kalil, E., & Habeeb, M. (2021). Predictors of early re-bleeding and mortality in patients with first attack of gastric variceal hemorrhage. Medical Journal of Viral Hepatitis, 5(3), 14–21.
Jachs, M., & Reiberger, T. (2021). Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clinics in Liver Disease, 25(2), 311–326.
Laleman, W., Vanderschueren, E., Mehdi, Z. S., Wiest, R., Cardenas, A., & Trebicka, J. (2024). Endoscopic procedures in hepatology: Current trends and new developments. Journal of Hepatology, 80(1), 124–139.
Larrue, H., Allaire, M., Weil-Verhoeven, D., Barge, S., Thabut, D., Payance, A., & Guiu, B. (2024). French guidelines on TIPS: Indications and modalities. Liver International, 44(9), 2125–2143.
Lesmana, C. R. A., Raharjo, M., & Gani, R. A. (2020). Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clinical and Molecular Hepatology, 26(4), 444–460.
Li, C. Z., Cheng, L. F., Li, Q. S., Wang, Z. Q., & Yan, J. H. (2013). Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis. World Journal of Gastroenterology, 19(40), 6849–6856.
Misra, V., Agrawal, R., & Misra, S. P. (2021). Portal hypertensive vasculopathy - An entity worth remembering with non-neoplastic gastrointestinal lesions. Indian Journal of Pathology and Microbiology, 64(5), S32–S42.
Mohammed, S. E. A., Abdo, A. E., & Mudawi, H. M. Y. (2016). Mortality and Rebleeding Following Variceal Haemorrhage in Liver Cirrhosis and Periportal Fibrosis. World Journal of Hepatology, 8(31), 1336–1342.
Muljono, D. H. (2017). Epidemiology of Hepatitis B and C in Republic of Indonesia. EJOHG: Euroasian Journal of Hepato-Gastroenterology, 7(1), 55–59.
Nagesh, V. K., Pulipaka, S. P., Bhuju, R., Martinez, E., Badam, S., Nageswaran, G. A., & Mansour, C. (2025). Management of gastrointestinal bleed in the intensive care setting, an updated literature review. World Journal of Critical Care Medicine, 14(1), 1–22.
Nelson, N. P., Easterbrook, P. J., & McMahon, B. J. (2016). Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. Clinics in Liver Disease, 20(4), 607–628.
Nguyen, M. H., Wong, G., Gane, E., Kao, J.-H., & Dusheiko, G. (2020). Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews, 33(2), 1–38.
Oh, J. H., & Sinn, D. H. (2024). Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives. Journal of Liver Cancer, 24(1), 47–56.
Padraic, M. (1992). The Pathogenesis of Variceal Rupture. Gastrointestinal Endoscopy Clinics of North America, 2(1), 1–15.
Pallio, S., Melita, G., Shahini, E., Vitello, A., Sinagra, E., Lattanzi, B., & Maida, M. (2023). Diagnosis and Management of Esophagogastric Varices. Diagnostics, 13(6), 1–21.
Ried, K., Travica, N., Dorairaj, R., & Sali, A. (2020). Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutrition Research, 76(1), 37–51.
Sarma, M. Sen, & Seetharaman, J. (2021). Pediatric non-cirrhotic portal hypertension: Endoscopic outcome and perspectives from developing nations. World Journal of Hepatology, 13(10), 1269–1288.
Scrutton, J., Wallace, J., & Wait, S. (2018). Situation Analysis of Viral Hepatitis in Indonesia : A Policy Report. Coalition Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), 3(2), 44.
Seo, Y. S. (2018). Prevention and management of gastroesophageal varices. Clinical and Molecular Hepatology, 24(1), 20–42.
Smith, R. E., Friedman, A. D., Murchison, J. A., Tanner, S. B., Smith, P. A., & Dollar, B. T. (2020). Acute Life-Threatening Complications of Portal Hypertension: a Review of Pathophysiology, Incidence, Management, and Cost. SN Comprehensive Clinical Medicine, 2(9), 1628–1645.
Sun, X., & Li, X. (2023). Editorial: Aging and chronic disease: public health challenge and education reform. Front. Public Health, 11(1), 1–3.
Yo, E. C., & Nursyirwan, S. A. (2024). Secondary Prevention of Esophageal Variceal Bleeding Using Transjugular Intrahepatic Portosystemic Shunt Compared to Endoscopic Band Ligation plus Beta-Blocker. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 24(3), 275–283.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Tasya Fabiola Alim
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
